Metadoxil

Metadoxine, the active ingredient in Metadoxil, is a hepatoprotective agent presented as a solution for injection for intramuscular and intravenous use. It is indicated for the management of alcoholic liver disease, helping to improve hepatic metabolism of ethanol and supporting liver function in adult patients. The formulation is designed for use in clinical settings under professional supervision.

GNH USA supplies Metadoxil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company adheres to EU quality standards and provides regulatory documentation for importers.

Metadoxil (metadoxine) is used in the management of alcoholic liver disease, a condition affecting hepatic metabolism and function. - Alcoholic liver disease: improves ethanol metabolism and supports overall liver function. - Alcoholic hepatitis: reduces hepatic inflammation and aids recovery. - Alcoholic cirrhosis: helps stabilize liver enzymes and may slow disease progression.

Metadoxil may cause adverse reactions that vary in frequency and severity.

Common Side Effects: - Injection site pain: mild to moderate discomfort at the site of administration. - Nausea: transient feeling of queasiness after dosing. - Headache: mild to moderate headache occurring shortly after injection. - Dizziness: occasional light‑headedness without loss of consciousness. - Transient elevation of liver enzymes: mild increase detected in routine labs.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response requiring immediate medical attention. - Severe hepatic failure: worsening of liver function in susceptible individuals. - Thrombocytopenia: significant drop in platelet count leading to bleeding risk. - Acute renal impairment: sudden decrease in kidney function. - Hypotension: marked drop in blood pressure following rapid intravenous administration.

Metadoxil should be used with careful clinical monitoring and adherence to safety guidelines. - Liver function monitoring: assess baseline and periodic liver enzymes during therapy. - Avoid in severe hepatic impairment: contraindicated when liver failure is advanced. - Caution with renal dysfunction: adjust use if significant kidney disease is present. - Assess for hypersensitivity: discontinue if signs of allergic reaction appear. - Pregnancy and lactation: safety not established; weigh risks and benefits. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Metadoxil may interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Concurrent hepatotoxic drugs: increased risk of liver injury. - Alcohol consumption: may counteract therapeutic benefit and worsen liver damage. - MAO inhibitors: potential for unpredictable metabolic effects.

Moderate Interactions (Monitor Closely): - Anticoagulants (e.g., warfarin): monitor coagulation parameters. - CYP450 substrates: possible alteration of drug metabolism. - Diuretics: watch for electrolyte disturbances.